INOVIQ Exosome Diagnostic Solutions

Board and Management | Healthcare, corporate & commercial experience For personal use only 4 DR GEOFF CUMMING Non-Executive Chairman Healthcare and biotechnology director with extensive diagnostics industry experience. Previously Managing Director Roche Diagnostic Systems (Oceania), MD/CEO Biosceptre International Ltd and MD/CEO of Anteo Diagnostics Ltd. Currently NED AnteoTech Ltd. MAX JOHNSTON Non-Executive Director Healthcare industry director and international business leader with extensive experience across medtech, pharmaceuticals, consumer healthcare and consumer goods. Previously President and CEO of Johnson & Johnson Pacific, Chairman of AusCann Ltd, NED of PolyNovo Ltd, Medical Developments International Ltd, Tissue Repair Ltd and CannPal Animal Therapeutics Ltd. PHILIP POWELL Non-Executive Director Healthcare industry director and chartered accountant with extensive investment banking experience specialising in capital raisings, IPOs, mergers and acquisitions and other transactions across pharma, food and agriculture. Previously at OAMPS Ltd and Arthur Andersen, and NED at Polynovo Ltd and Medical Developments International Ltd. Currently NED RMA Global Ltd. DR LEEARNE HINCH Chief Executive Officer Biotechnology CEO with a successful track record in corporate development, capital raising, product development, commercialisation and licensing. Past leadership and consulting roles in ASX- listed biotechnology, multinational and private companies across diagnostics, devices, therapeutics and animal health including Eustralis Pharmaceuticals, HealthLinx, OBJ, Holista Colltech, Virbac and Mars. DR GREG RICE Chief Scientific Officer Internationally recognized, award winning scientist with over 35 years' experience and a successful track record in oncology research, exosome science, biomarker discovery, and diagnostics development. Previous leadership roles in academia and industry including at Uni Queensland Centre for Clinical Research, Baker Heart Institute, University of Melbourne, Monash University and Health Linx. MARK EDWARDS CFO & Company Secretary Highly experienced finance executive with expertise in financial leadership and management, corporate governance, investor relations and corporate transactions. Previous senior roles in ASX listed pharmaceutical, medical device and healthcare companies, including Medical Developments International and Cogstate. INOVIQ

View entire presentation